Dr. Suzanne Morgan is a Patient Services and Market Access Leader specializing in rare diseases, with over 30 years of experience in biotech. Currently serving as the Executive Director and Head of Market Access at Stealth BioTherapeutics, they are responsible for the U.S. market access strategy for FORZINITY™, an ultra-rare therapy. Dr. Morgan has held various leadership roles, including President and CEO at SLM Access Strategies, LLC, where they developed market access strategies for startup biotech firms. They previously received the Standards of Leadership Award from Johnson & Johnson for excellence in leadership during their tenure at Centocor and Janssen Biotech. Dr. Morgan is a graduate of the University of Iowa.
This person is not in the org chart
This person is not in any teams
This person is not in any offices